Statin use and risk of diabetes mellitus

Código QR

Statin use and risk of diabetes mellitus

At present time four groups of medications are used to correct dyslipidemia: bile acid sequestrants, niacin, fibric acid derivatives andstatins. During last years statins' potential to increase risk of type 2 diabetes mellitus (T2DM) is actively discussed, though no commonopinion about the poss...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Oksana Mikhailovna Drapkina, Marina Viktorovna Kostyukevich
Formato:	article
Lenguaje:	EN RU
Publicado:	Endocrinology Research Centre 2012
Materias:	statins insulin resistance diabetes mellitus atherosclerosis metformin Nutritional diseases. Deficiency diseases RC620-627
Acceso en línea:	https://doaj.org/article/b31942a2c8ca41908837b15aa3f8aa17
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Statins and diabetes mellitus: price of collaboration
por: Andrey Alexeevich Aleksandrov, et al.
Publicado: (2012)

Risk of oncological diseases in patients with diabetes mellitus
por: Gagik Radikovich Galstyan
Publicado: (2009)

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment
por: Tatiana Ivanovna Romantsova, et al.
Publicado: (2013)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
por: Ekaterina Viktorovna Artemova, et al.
Publicado: (2012)

Prescribing frequency and adherence to statins in outpatients with type 2 diabetes mellitus and comorbid cardiovascular diseases
por: Victoriya N. Serebryakova, et al.
Publicado: (2021)

Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
por: Lev Mikhaylovich Bershteyn, et al.
Publicado: (2014)

Diabetes mellitus due to biliary recurrent pancreatitis. Case report
por: Elena Alexandrovna Kharlashina, et al.
Publicado: (2011)

Telomere length and vascular wall in patients with Type 2 Diabetes Mellitus
por: Ekaterina Nailyevna Dudinskaya, et al.
Publicado: (2014)

Efficacy and safety of metformin for the treatment of gestational diabetes: a new approach to the problem
por: Anna I. Sazonova, et al.
Publicado: (2016)

Prevalence of combined atherosclerotic vascular lesions in patients with diabetes mellitus
por: Svetlana Alexandrovna Gracheva, et al.
Publicado: (2012)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010)

Humalog Mix 25 in the treatment of type 2 diabetes mellitus
por: Vladimir Ivanovich Zoloedov, et al.
Publicado: (2012)

Multidimensional effects of metformin in patients with type 2 diabetes
por: Lyudmila A. Ruyatkina, et al.
Publicado: (2017)

Functional activity and peripheral insulin resistance in patients with different types of onset of diabetes mellitus
por: Tatiana Vasil'evna Nikonova, et al.
Publicado: (2012)

The role of metformin in the modern strategy of treatment and prevention of type 2 diabetes mellitus
por: Olga Mikhailovna Smirnova
Publicado: (2010)

The experience with the use of insulin pump therapy in children and adolescents with type 1 diabetes mellitus
por: Nina Viktorovna Bolotova, et al.
Publicado: (2010)

Russian Association of Endocrinologists reports commencement of Amaril clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2012)

Insulin therapy during pregnancy in women with type 1 diabetes
por: V V Potin, et al.
Publicado: (2009)

Vascular channel reserves in patients with systemic atherosclerosis and type 2 diabetes mellitus
por: O V Kamenskaya, et al.
Publicado: (2013)

Genetic framework of type 2 diabetes mellitus
por: Irina Arkad'evna Bondar', et al.
Publicado: (2013)

Experience with sitagliptin (the first DPP-4 inhibitor) application to the treatment of type 2 diabetes mellitus in the Russian Federation:Results of the DIA-DA observation program
por: Marina Vladimirovna Shestakova
Publicado: (2010)

Novel approach to pathophysiology of type 2 diabetes mellitus
por: Emil' Kopeevich Mukhamedzhanov, et al.
Publicado: (2013)

Metformin and cancer mortality
por: Lev Mikhaylovich Bershteyn
Publicado: (2010)

Some mechanisms of inflammation development in type 2 diabetes mellitus
por: L. A. Bochkareva, et al.
Publicado: (2021)

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
por: Natalya Vladislavovna Zaytseva, et al.
Publicado: (2015)

Materials of the congress CHD and peripheral atherosclerosis treatment in diabetic patients
por: Victor Yur'evich Kalashnikov, et al.
Publicado: (2012)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
por: I Yu Demidova, et al.
Publicado: (2009)

Russian Association of Endocrinologists reports commencement of Glimecomb clinical use
por: Editorial team Diabetes Mellitus
Publicado: (2011)

Harold Himsworth, founder of diabetes classification: 105th anniversary of his birthday
por: Olga Sergeevna Fedorova
Publicado: (2010)

Genetic markers of insulin resistance in gestational diabetes
por: Tatiana Vasil'evna Sebko, et al.
Publicado: (2009)

Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
por: Tatiana Evgen'evna Taranushenko, et al.
Publicado: (2012)

Sulfonylureas in the modern strategy of therapy of type 2 diabetes
por: Lyudmila Viktorovna Nedosugova
Publicado: (2011)

Birth weight and length in offsprings of mothers with gestational diabetes mellitus due to mutations in GCK gene
por: Natalia A. Zubkova, et al.
Publicado: (2018)

Epidemiology of diabetes mellitus and microvascular complications
por: Oksana Vladimirovna Maslova, et al.
Publicado: (2011)

Characteristics of natural history of diabetes mellitus, manifested after Cushing disease treatment
por: Elena Viktorovna Peretokina, et al.
Publicado: (2012)

The role of phenofibrate in the treatment of microvascular complications of type 2 diabetes mellitus
por: Larisa Viktorovna Koshel', et al.
Publicado: (2009)

What are new opportunities for clinical practice the VERIFY study opens and which values for native diabetes patients? Joint conclusion on the advisory board results. November 6, 2019
por: Marina V. Shestakova, et al.
Publicado: (2020)

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
por: Elena Efimovna Petryaykina, et al.
Publicado: (2009)

Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
por: Vadim V. Genkel, et al.
Publicado: (2018)

Factors associated with abnormal cardio-ankle vascular index in patients with type 2 diabetes and prediabetes
por: Aleksei N. Sumin, et al.
Publicado: (2016)